Research Article

Prevalence of Bacterial Vaginosis and Associated Risk Factors among Women Complaining of Genital Tract Infection

Table 4

Percentage of in vitro antibacterial susceptibility pattern of Gram-negative bacteria isolates ().

SpeciesPattern Antibacterial drugs
AMAMCSXTTECNCROCIPTOBAK

E. coli (43)S23.332.660.518.683.776.779.186.0486.04
I0716.34.7007.000
R76.760.523.376.716.323.314.013.9613.96
K. pneumoniae (28)S14.314.314.317.878.560.757.178.582.1
I7.17.10000000
R78.678.685.782.121.139.042.821.117.8
K. ozaenae (4)S000050.050.050.075.0100
I000050.00000
R100100100100050.050.025.00
E. aerogenes (17)S017.628.15.970.670.658.876.782.35
I17.611.818.817.65.911.8000
R82.470.653.176.523.517.641.223.517.64
C. freundii (6)S0050.033.3383.366.683.3100100
I000000000
R10010050.066.616.6733.3316.6700
C. diversus (2)S000050.50.050.050.050.0
I000000000
R10010010010050.050.050.050.050.0
P. mirabilis (1)S100100100100100100100100100
I000000000
R000000000
P. rettgeri (4)S10050.050.050.010075.0100100100
I000000000
R050.050.050.0025.0000

Total isolatesS1822.839187968.569.582.885.7
I4.76.69.54.72.81.92.800
R77.170.651.577.318.229.627.717.214.3

AMP: ampicillin; AMC: amoxicillin/clavulanate; SXT: trimethoprim/sulfamethoxazole; CRO: ceftriaxone; CIP: ciprofloxacin; CN: gentamicin; TE: tetracycline; TOB: tobramycin; AK: amikacin; S: sensitive; R: resistance; P: pattern.